Teng-Hung Yu Selected Research

Thrombosis (Thrombus)

3/2006	Concentration of soluble P-selectin and white blood cell counts in infarct coronary arteries in patients with acute myocardial infarction differ from the systemic circulation.
10/2005	Levels and value of soluble P-selectin following acute myocardial infarction: evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain.
1/2004	Effects and safety of intracoronary thrombectomy using transradial application of the PercuSurge distal balloon protection system in patients with early or recent myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Teng-Hung Yu Research Topics

Disease

14	Chronic Renal Insufficiency 03/2022 - 01/2013
13	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 06/2009
11	Myocardial Infarction 01/2012 - 12/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2007
5	Stable Angina 01/2021 - 09/2005
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2010
4	ST Elevation Myocardial Infarction 10/2018 - 01/2012
4	Mitral Valve Stenosis (Mitral Stenosis) 01/2005 - 11/2003
3	Hypertension (High Blood Pressure) 01/2022 - 01/2017
3	Left Ventricular Dysfunction 01/2021 - 02/2009
3	Heart Failure 01/2021 - 01/2017
3	Obesity 09/2019 - 10/2013
3	Stroke (Strokes) 10/2018 - 09/2009
3	Coronary Disease (Coronary Heart Disease) 10/2018 - 06/2009
3	Atherosclerosis 11/2013 - 09/2009
3	Atrial Fibrillation 10/2006 - 04/2004
3	Thrombosis (Thrombus) 03/2006 - 01/2004
3	Infarction (Infarctions) 03/2006 - 01/2004
2	Anemia 05/2021 - 01/2017
2	Uremia 05/2021 - 09/2018
2	Acidosis 05/2021 - 09/2018
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2021 - 09/2018
2	Inflammation (Inflammations) 01/2021 - 10/2005
2	Neoplasms (Cancer) 01/2021 - 01/2017
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2010
2	Acute Coronary Syndrome 10/2018 - 01/2017
2	Diabetes Mellitus 01/2017 - 01/2016
2	Pathologic Constriction (Stenosis) 11/2013 - 05/2007
1	Fatty Liver 01/2022
1	Insulin Resistance 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Hypoxia (Hypoxemia) 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2018
1	Virus Diseases (Viral Diseases) 01/2017
1	Liver Neoplasms (Liver Cancer) 01/2017
1	Infections 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Alcoholic Fatty Liver 01/2017
1	Chronic Hepatitis B 01/2017
1	Chronic Hepatitis C 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Angina Pectoris 01/2017
1	Pruritus (Itching) 01/2016
1	Renal Insufficiency (Renal Failure) 11/2014

Drug/Important Bio-Agent (IBA)

7	Nicotinamide PhosphoribosyltransferaseIBA 01/2021 - 09/2009
6	4-cresol sulfateIBA 05/2021 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2010
5	CreatinineIBA 01/2022 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2005
5	EnzymesIBA 01/2021 - 09/2009
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2017
4	AlbuminsIBA 01/2022 - 01/2016
4	C-Reactive ProteinIBA 01/2021 - 11/2013
4	P-SelectinIBA 03/2006 - 11/2003
3	Uric Acid (Urate)IBA 01/2022 - 01/2016
3	Triglycerides (Triacylglycerol)IBA 12/2021 - 06/2009
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 06/2009
3	IndicanIBA 05/2021 - 02/2013
3	AdiponectinIBA 01/2021 - 01/2010
3	ImmunosorbentsIBA 01/2021 - 01/2017
3	AdipokinesIBA 01/2017 - 06/2009
3	CalciumIBA 01/2016 - 06/2009
3	SelectinsIBA 03/2006 - 09/2005
2	Fatty Acid Binding Protein 3IBA 01/2022 - 01/2021
2	Uremic ToxinsIBA 05/2021 - 01/2016
2	hippuric acidIBA 05/2021 - 09/2018
2	Fatty Acid-Binding ProteinsIBA 01/2020 - 01/2019
2	Serum AlbuminIBA 10/2018 - 11/2013
2	WD repeat containing planar cell polarity effectorIBA 10/2018 - 10/2013
2	CholesterolIBA 01/2017 - 06/2009
2	HDL CholesterolIBA 01/2017 - 06/2009
2	omega-Chloroacetophenone (Mace)IBA 01/2017 - 01/2010
2	Endothelins (Endothelin)IBA 05/2005 - 02/2004
2	Endothelin-1 (Endothelin 1)IBA 05/2005 - 02/2004
1	AntioxidantsIBA 03/2022
1	Antiviral Agents (Antivirals)IBA 03/2022
1	Antidepressive Agents (Antidepressants)IBA 03/2022
1	MineralsIBA 05/2021
1	Lipocalin-2IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	LipocalinsIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	NitrogenIBA 10/2018
1	Histones (Histone)IBA 10/2018
1	Immunoglobulin G (IgG)IBA 06/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	ResistinIBA 01/2017
1	Phosphorus (Red Phosphorus)IBA 01/2016
1	E-SelectinIBA 11/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2013
1	Wnt-5a ProteinIBA 10/2013

Therapy/Procedure

6	Percutaneous Coronary Intervention 10/2018 - 12/2002
2	Renal Dialysis (Hemodialysis) 05/2021 - 09/2018
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2017 - 05/2007
2	Therapeutics 01/2010 - 01/2004
1	Stents 01/2017